Status:
COMPLETED
The Incidence of Gallstones After Gastrectomy
Lead Sponsor:
Hepatopancreatobiliary Surgery Institute of Gansu Province
Conditions:
Gallstone
Gastric Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
To provide preventive and therapeutic strategies for participants with gallstones after gastric cancer by comparing the risk of postoperative gallbladder stone formation with two different resection r...
Detailed Description
A large number of clinical studies have found that the incidence of gallstones in patients after radical gastric cancer surgery is higher than that in the normal population. However, the pathogenesis ...
Eligibility Criteria
Inclusion
- Patients with Gastric Cancer underwent Gastrectomy
Exclusion
- Age less than 18 years or age greater than 75 years;
- Not Roux-en-Y reconstruction;
- R0 excision is not achieved;
- Previous history of upper abdominal surgery, such as cholecystectomy, gastrectomy;
- Preoperative gallbladder diseases, such as gallstones, gallbladder polyps, chronic cholecystitis;
- Preoperative neoadjuvant chemotherapy or radiotherapy;
- Previous history of malignant tumours;
- Patients with mental or developmental abnormalities or women during pregnancy or breastfeeding;
- Gastric perforation or bleeding leading to emergency surgery;
- Palliative surgical treatment;
- Incomplete case information.
Key Trial Info
Start Date :
July 21 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2024
Estimated Enrollment :
531 Patients enrolled
Trial Details
Trial ID
NCT05965466
Start Date
July 21 2023
End Date
November 16 2024
Last Update
November 19 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hepatopancreatobiliary Surgery Institute of Gansu Province
Lanzhou, Gansu, China, 730000
2
Wuwei Tumor Hospital
Wuwei, Gansu, China, 733099